Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Simon S Yu

1PUBLICATIONS

10CO-AUTHORS

Molecular medicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 15, 2020

Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib.

Yuting Sun, Brooke A Meyers, Barbara Czako

Pageof 1

Frequent Collaborators

1 joint publications

Yuting Sun

1 joint publications

Paul Leonard

1 joint publications

Qi Wu

1 joint publications

Connor A Parker

1 joint publications

Jason B Cross

1 joint publications

Jason P Burke

1 joint publications

Ningping Feng

1 joint publications

Justin K Huang

1 joint publications

Sahil Seth

1 joint publications

Timothy P Heffernan

Frequent Collaborators

1 joint publications

Yuting Sun

1 joint publications

Paul Leonard

1 joint publications

Qi Wu

1 joint publications

Connor A Parker

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

See more related videos